Ignite Creation Date:
2024-05-06 @ 1:52 PM
Last Modification Date:
2024-10-26 @ 1:21 PM
Study NCT ID:
NCT04143750
Status:
COMPLETED
Last Update Posted:
2020-04-03
First Post:
2019-10-21
Brief Title:
The Mass Balance and Biotransformation of 14C Vicagrel in Healthy Man
Sponsor:
Jiangsu vcare pharmaceutical technology co LTD
Organization:
Jiangsu vcare pharmaceutical technology co LTD
Study Overview
Official Title:
The Mass Balance and Biotransformation Study of 14C Vicagrel in Chinese Healthy Adult Male Volunteers
Status:
COMPLETED
Status Verified Date:
2020-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study was designed to evaluate the mass balance and biotransformation after single-dose of 14CVicagrel orally in Chinese healthy male volunteers revealing the overall pharmacokinetic characteristics of vicagrel in humans and providing a reference for the rational administration
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None